GT Biopharma (GTBP) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free GTBP Stock Alerts $3.15 +0.30 (+10.53%) (As of 06/11/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 21, 2024 | marketwatch.comGT Biopharma Shares Rise 16% After Direct Offering PricesMay 21, 2024 | markets.businessinsider.comGT Biopharma Announces $3.2 Mln Direct Offering Of Shares; Stock UpMay 21, 2024 | globenewswire.comGT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 20, 2024 | investorplace.comWhy Is GT Biopharma (GTBP) Stock Up 143% Today?May 18, 2024 | nasdaq.comGT Biopharma, Inc. Common Stock (GTBP)May 16, 2024 | benzinga.comRaymond W. Urbanski's Net WorthMay 16, 2024 | investorplace.comGTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024May 15, 2024 | msn.comGT Biopharma reports Q1 resultsMay 15, 2024 | globenewswire.comGT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMarch 27, 2024 | benzinga.comRecap: GT Biopharma Q4 EarningsMarch 26, 2024 | globenewswire.comGT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 25, 2024 | msn.comGT Biopharma (GTBP) Price Target Increased by 2900.00% to 153.00February 14, 2024 | finance.yahoo.comGTBP Feb 2024 2.500 callFebruary 5, 2024 | marketbeat.comTrading was temporarily halted for "GTBP" at 07:02 PM with a stated reason of "News pending."February 2, 2024 | finance.yahoo.comGT Biopharma, Inc. (GTBP)February 2, 2024 | msn.comGT Biopharma Announces Reverse Stock Split UpdateFebruary 2, 2024 | benzinga.comGT Biopharma Stock (NASDAQ:GTBP), Short Interest ReportFebruary 1, 2024 | finance.yahoo.comGT Biopharma, Inc. Announces 1-for-30 Reverse Stock SplitDecember 14, 2023 | markets.businessinsider.comBuy Rating for GT Biopharma: High Efficacy and Expanded Potential in Oncology TherapeuticsDecember 6, 2023 | finance.yahoo.comLeading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of StockholdersDecember 4, 2023 | msn.comGT Biopharma submits IND to FDA for CD33+ leukemia therapyDecember 4, 2023 | finance.yahoo.comGT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ LeukemiaNovember 23, 2023 | markets.businessinsider.comGT Biopharma: Strong Q3 Performance and Promising Pipeline Progression Justify Buy RatingNovember 6, 2023 | finance.yahoo.comGT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNovember 1, 2023 | msn.comGT Biopharma GAAP EPS of -$0.06November 1, 2023 | finance.yahoo.comGT Biopharma Reports Third Quarter 2023 Financial ResultsAugust 24, 2023 | finance.yahoo.comGT Biopharma, Inc. (GTBP) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowAugust 8, 2023 | markets.businessinsider.comH.C. Wainwright Remains a Buy on GT Biopharma (GTBP)August 7, 2023 | finanznachrichten.deGT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2023 Financial ResultsAugust 7, 2023 | finance.yahoo.comGT Biopharma Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comGT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023June 2, 2023 | msn.comHere's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock NowMay 19, 2023 | msn.comAll You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to BuyMay 18, 2023 | msn.comHC Wainwright & Co. Reiterates GT Biopharma (GTBP) Buy RecommendationMay 17, 2023 | msn.comEF Hutton Reiterates GT Biopharma (GTBP) Hold RecommendationMay 16, 2023 | finanznachrichten.deGT Biopharma, Inc.: GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cara Therapeutics (CARA), GT Biopharma (GTBP) and Spruce Biosciences (SPRB)May 15, 2023 | finance.yahoo.comGT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateApril 3, 2023 | markets.businessinsider.comGT Biopharma (GTBP) Gets a Buy from H.C. WainwrightApril 2, 2023 | benzinga.comGT Biopharma Inc Up 20.52% To $0.56 After Earnings MissApril 1, 2023 | finanznachrichten.deGT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateApril 1, 2023 | benzinga.comGT Biopharma Stock (NASDAQ:GTBP), DividendsMarch 31, 2023 | markets.businessinsider.comEF Hutton Keeps Their Hold Rating on GT Biopharma (GTBP)March 30, 2023 | finance.yahoo.comGT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateFebruary 24, 2023 | finance.yahoo.comGT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual ConferenceFebruary 2, 2023 | finance.yahoo.comGT Biopharma Issues Open Letter to Shareholders Detailing Recent ActivitiesDecember 30, 2022 | msn.comGT Biopharma slips on $6.5M stock offeringDecember 14, 2022 | finance.yahoo.comGT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical OfficerDecember 12, 2022 | msn.comFate Therapeutics hits 52-week low after preclinical data on leukemia treatmentDecember 12, 2022 | finance.yahoo.comGT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address "If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock." (Ad)"I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL at $0.35 and AMZN under $2.50. Now, he says ONE stock could be the single smartest way to pass wealth to your family. It's outperformed traditional inheritance vehicles like annuities, life insurance, real estate, and gold by as much as 13 times, with tax advantages not many other investments offer. He reveals the name and ticker for free, right here. GTBP Media Mentions By Week GTBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTBP News Sentiment▼1.900.79▲Average Medical News Sentiment GTBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTBP Articles This Week▼10▲GTBP Articles Average Week Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lumos Pharma News Synlogic News Orgenesis News Aytu BioPharma News Sensei Biotherapeutics News GlycoMimetics News VBI Vaccines News Alaunos Therapeutics News Talphera News Akari Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GTBP) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | Sponsored"If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock.""I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored